Fulgent Genetics
FLGT
$20.10
Share price
0.35%
Change (1 day)
-30.93%
Change (1 year)
Operating Margin for Fulgent Genetics (FLGT)
Operating Margin as of April 2024 (TTM): -12.40%
According to Fulgent Genetics 's latest financial reports and stock price the company's current Operating Margin is -12.40%. At the end of 2021 the company had an Operating Margin of 68.24%.
Operating Margin history for Fulgent Genetics from 2016 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 68.24% | -1.35% |
| 2020 | 69.17% | 5400.86% |
| 2019 | 1.26% | -105.79% |
| 2018 | -21.71% | 35.52% |
| 2017 | -16.02% | -34.46% |
| 2016 | -24.45% | -53.04% |
| 2015 | -52.06% | -32.8% |
| 2014 | -77.46% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 PAVmed
PAVM | -13,857.60% | 111,654.84% | 🇺🇸 USA |
 Philips PHG | -9.70% | -21.77% | 🇳🇱 Netherlands |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.